Optimized Stent Performance

COBRA PzF NCS is the world’s first non-drug eluting, nanocoated stent that allows physicians to safely and effectively treat their patients who may benefit from a short, minimum 1-month DAPT requirement.5
The revolutionary COBRA PzF NCS is a new nanocoated, non drug-eluting stent that allows physicians to safely and effectively treat their patients who may benefit from a short, minimum 1-month DAPT requirement.1
The revolutionary COBRA PzF NCS is a new nanocoated, non drug-eluting stent that allows physicians to safely and effectively treat their patients who may benefit from a short, minimum 1-month DAPT requirement.1
In the eCOBRA all-comers study, COBRA PzF NCS demonstrated an excellent safety profile with low TLR in patients at high risk of bleeding and stent thrombosis in a real-world setting.2
“The study demonstrated good follow-up with excellent numbers…One of the numbers I was most impressed with was the need for repeat revascularization…given that its [COBRA’s] major feature is thromboresistance, 4% TLR is really quite spectacularly good.”
-Dr. Philip Urban, MD, Medical Co-Director CERC, Paris, France
Click here to watch the complete interview.
Late Stent Thrombosis2 (Definite/Probable)
TLR‡2
High Risk Patients2
Polyzene-F is a nano-thin surface coating that has been studied extensively in the past 20+ years, demonstrating thrombo-resistant, anti-inflammatory and rapid healing effects in preclinical studies.3-7*
Polyzene-F is a nano-thin surface coating that has been studied extensively in the past 20+ years, demonstrating thrombo-resistant, anti-inflammatory and rapid healing effects in preclinical studies.3-7*
The COBRA PzF coronary stent is FDA and CE approved and commercially available for purchase. Contact a CeloNova sales representative today.